Evaluation of the Safety, Tolerability and Pharmacokinetics of Intravenous FL058 Administered in Healthy Subjects(SAD)
Clinical trial NCT05058118 · COMPLETED
Trial details
- NCT number
- NCT05058118
- Sponsor
- Qilu Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-08
- Primary completion
- 2020-06-03
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.